Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease
Clinical trial NCT00533273 · COMPLETED
Trial details
- NCT number
- NCT00533273
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-09-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.